Buy Sun Pharma, Reliance Infra, YES Bank, says Anand Rathi Reasearch

Nifty outlook and technical calls by Jay Anand Thakkar ,CMT -Assistant Vice President - Equity Research, Anand Rathi Research

Buy Sun Pharma, Reliance Infra, YES Bank, says Anand Rathi Reasearch
Jay Anand Thakkar Mumbai
Last Updated : Jun 21 2018 | 6:40 AM IST
Nifty outlook and technical calls by Jay Anand Thakkar ,CMT -Assistant Vice President - Equity Research, Anand Rathi Research:

Nifty outlook

Nifty has been consolidating in this 300 points range as anticipated. Now, till this range of 10930 to 10650 is not broken of the either side we will see further consolidation.  Next week being an expiry week the probability of breakout or breakdown seem less likely as we have seen 10800 & 10900 call  strike have highest open interest whereas 10600 & 10700 put strike have highest open interest. However, if there is breakout form this range there will be minimum 300 points trend form thereon

SUN PHARMA- BUY
Target: Rs 585.00 
Stop Loss: Rs 554.00

SUNPHARMA seems to have completed a wave 4 correction on daily & hourly charts. Stock has retraced 23.6% of its wave 3 and now a wave 5 on the up side is likely. The momentum indicators on the daily as well as hourly charts are still on buy mode; hence there is better risk reward on the buy side.

RELIANCE INFRA - BUY 
Target: Rs 460.00 
Stop Loss: Rs 432

RELIANCE INFRA has clearly provided a breakout form a sideways consolidation in its last trading section. The stock has formed bullish inverse hand & shoulder pattern on the daily charts which is positive sign going forward.  The way the momentum indicators are in the buy mode on daily & hourly charts the break on the upside is quite likely. Hence, we recommend initiating buy position on the stock.

YES BANK- BUY 
Target: Rs 350.00 
Stop Loss: Rs 329.00

YES BANK as smartly provided a breakout form a falling wedge pattern that is formed in its wave C of wave 4 on the daily chart. Now the stock seem to have started wave 5 on the upside wherein its  short-term target come to 350, so we recommend initiated buy on it with stop loss of 329.

Disclaimer: The analyst may have positions in any or all the stocks mentioned above.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story